Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetazolamide for AMS prevention in older lowlanders
NCT03561675Phase 4Completed
- Sponsor
- University of Zurich
- Start
- May 2018
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of acetazolamide in acute mountain sickness (AMS), sponsored by University of Zurich. Started May 2018; status: completed.
02
Drugs
acetazolamide
03
Conditions
acute mountain sickness (AMS)
Beyond the preview
Go deeper on NCT03561675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03561675.